A Phase II, Single Arm, Open Label Study to Evaluate the Efficacy and Safety of Trastuzumab and Vinorelbine in Advanced Breast Cancer Patients With HER2 Negative Primary Tumours and HER2 Positive Circulating Tumour Cells.
Phase of Trial: Phase II
Latest Information Update: 30 May 2017
At a glance
- Drugs Trastuzumab (Primary) ; Vinorelbine
- Indications Advanced breast cancer; Male breast cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 10 Nov 2015 Status changed from active, no longer recruiting to discontinued, as reported by ClinicalTrials.gov.
- 02 Oct 2014 Status changed from recruiting to active, no longer recruiting, as per ClinicalTrials.gov record.